NEET-PG 2015 - Community Medicine Practice Questions

Q: What is a key benefit of Randomized Controlled Trials (RCTs) in clinical research?

They minimize selection bias.. ***They minimize selection bias.*** - **Randomization** in RCTs ensures that participants have an equal chance of being assigned to any of the treatment groups, thereby balancing potential **confounding factors** across groups. - This balance helps to ensure that any observed differences in outcomes between groups are more likely due to the intervention being studied rather than pre-existing differences among participants, thus minimizing **selection bias**. *They can be conducted more quickly than other study types.* - RCTs often require **extensive planning**, recruitment, and follow-up periods, making them one of the **most time-consuming** study designs. - The need for sufficient **power** to detect meaningful differences often translates into longer study durations. *They are ideal for studying rare diseases.* - Due to the requirement for **large sample sizes** to demonstrate statistical significance, RCTs are **not practical** for diseases with low prevalence. - Recruiting enough participants with a rare disease for an RCT can be extremely challenging and often **unfeasible**. *They are generally less expensive than other study types.* - RCTs are typically among the **most expensive** study designs because they involve extensive participant recruitment, intervention administration, data collection, and long-term follow-up. - The costs associated with staff, resources, and monitoring for ethical compliance contribute to their **high financial burden**.

Q: Most commonly used blinding technique in epidemiological studies?

Double blinding. ***Double blinding*** - In **double blinding**, neither the **participants** nor the **researchers** administering the intervention and collecting data know who is in the treatment group versus the control group. - This method is widely used to prevent **observer bias** from the researchers and **participant bias** (e.g., placebo effect) from the subjects, thereby strengthening the study's internal validity. *Single blinding* - In **single blinding**, only the **participants** are unaware of their assignment to either the treatment or control group. - While it helps reduce participant bias, the **researchers' knowledge** of group assignments can still introduce **observer bias**, making it less rigorous than double blinding. *Triple blinding* - **Triple blinding** extends double blinding by ensuring that the **data analysts** are also unaware of the participant group assignments. - This technique further minimizes bias in the **interpretation and analysis of results**, but it is less commonly implemented due to its complexity and increased logistical challenges compared to double blinding. *None of the options* - This option is incorrect because **blinding techniques** are fundamental tools in epidemiological studies and clinical trials to ensure the objectivity and reliability of research findings. - **Blinding** helps eliminate conscious and unconscious biases that could otherwise influence study outcomes.

Q: Which one of the following is NOT a utilization rate?

Population bed ratio. ***Population bed ratio*** - The **population bed ratio** indicates the number of available beds per unit of population, reflecting healthcare **resource availability** rather than resource utilization. - It is a measure of healthcare capacity and access, not how intensively those beds are being used. *Bed occupancy rate* - The **bed occupancy rate** measures the proportion of available hospital beds that are occupied over a given period, directly indicating the **utilization** of bed resources. - A higher rate suggests more efficient use of beds, while a lower rate may indicate underutilization or excess capacity. *Bed turnover ratio* - The **bed turnover ratio** calculates the number of patients discharged per bed over a specific period, reflecting how frequently beds are being used and re-used. - It indicates the **efficiency** with which beds are being utilized and cleared for new patients. *Average length of stay* - The **average length of stay (ALOS)** represents the average number of days a patient remains hospitalized, which directly relates to the **duration of bed utilization** per patient. - A shorter ALOS can indicate more efficient use of beds, while a longer ALOS may suggest higher resource consumption per patient.

Q: Which study design is most effective for investigating rare adverse effects of a drug?

Case-control study. ***Case-control study*** - This design starts by identifying individuals with the **rare adverse effect (cases)** and a control group without the effect to look back for exposure to the drug. - It is efficient for studying rare outcomes because it doesn't require following a large population for a long time to observe few events. *Cohort study* - A **cohort study** follows a group of individuals exposed and unexposed to a drug forward in time to observe outcomes. - While good for common outcomes, it would require an **extremely large sample size** and a long follow-up period to observe rare adverse drug effects. *Cross-sectional study* - A **cross-sectional study** assesses exposure and outcome simultaneously at a single point in time. - This design is suitable for determining **prevalence** but cannot establish temporal relationships between drug exposure and rare adverse effects, nor is it efficient for rare outcomes. *Clinical trial/experimental study* - **Clinical trials** are primarily designed to test the efficacy and safety of new interventions, usually focusing on common adverse effects. - They are generally **not powered** or long enough to detect rare adverse events, as such events would occur in very few participants, if any.

Q: Bladder cancer can occur in those who are working in dye industry for 25 years. Which study design is most appropriate for establishing a causal relationship between dye industry work and bladder cancer?

Cohort study. ***Cohort study*** - A **cohort study** tracks a group of individuals exposed to a risk factor (dye industry work) and a group not exposed over time to see who develops the outcome (bladder cancer). - This design allows for the calculation of **incidence rates** and relative risk, which are crucial for establishing a causal link, especially when the exposure is rare or specific. - Cohort studies establish **temporal relationship** (exposure precedes disease) and can demonstrate a **dose-response relationship**, both essential for proving causality. *Cross-sectional study* - A **cross-sectional study** assesses exposure and outcome simultaneously at a single point in time, making it difficult to determine the temporal sequence of events. - While it can identify associations, it cannot definitively establish a **cause-and-effect relationship** because it doesn't observe outcomes developing over time. *Case-control study* - A **case-control study** compares individuals with the outcome (cases) to individuals without the outcome (controls) and retrospectively looks for differences in past exposures. - While useful for studying **rare diseases** and can suggest associations, it is prone to **recall bias** regarding exposure history and cannot establish causality as definitively as cohort studies. *Randomized control trial* - A **randomized controlled trial (RCT)** involves randomly assigning participants to an intervention group or a control group and following them prospectively. - While RCTs provide the strongest evidence for causality, it would be **unethical** to intentionally expose people to a known carcinogen like dye industry chemicals for research purposes.

Q: Which of the following is an example of a case-control study?

PVC exposure and angiosarcoma of the liver. ***PVC exposure and angiosarcoma of the liver*** - This is a classic example of a **case-control study** where individuals with a rare disease (angiosarcoma of the liver) are identified (cases) and compared to a control group without the disease to determine past exposures (PVC). - The study looked back in time to identify differences in exposure between cases and controls. *Framingham heart study (cohort study)* - The Framingham Heart Study is a well-known **prospective cohort study** that has followed participants over time to observe the development of cardiovascular disease. - In a cohort study, researchers identify a group of individuals and follow them forward in time to see who develops the outcome of interest, making it different from a case-control design. *Doll & Hill Study (cohort study)* - The Doll & Hill study is a landmark **cohort study** that investigated the association between smoking and lung cancer by following a group of British doctors over several years. - This study started with healthy individuals and observed them over time to see who developed lung cancer, which is characteristic of a cohort design. *Thalidomide exposure and its association with teratogenicity* - While the thalidomide tragedy led to crucial epidemiological investigations, the initial identification of the association was often through **case series** or **descriptive epidemiology**, noting an unusual clustering of rare birth defects among infants whose mothers took thalidomide. - Subsequent studies might have incorporated case-control elements, but the prompt asks for an example of a case-control study, and this event itself is generally cited for its role in pharmacovigilance and observational studies rather than a single, classic case-control study example in the way "PVC and angiosarcoma" is.

Q: Immunity starts after how many days of yellow fever vaccination ?

7-10 days. ***Correct: 7-10 days*** - The **onset of immunity** after yellow fever vaccination typically occurs within **7-10 days** for most individuals. - This period is crucial for the body to develop a protective immune response, which is why travelers are advised to get vaccinated at least **10 days before potential exposure** as per WHO guidelines. - Approximately **95% of vaccinees** develop protective immunity by day 10. *Incorrect: 2-3 weeks* - While immunity continues to strengthen over this period, **initial protective immunity** is established earlier, typically by 7-10 days. - This option represents a slightly delayed timetable for the initial establishment of immunity. *Incorrect: 4-5 weeks* - This duration is significantly longer than the time required for the initial protective immunity to develop after yellow fever vaccination. - At this point, robust and **long-lasting immunity** would generally be established, but it's not when immunity "starts." *Incorrect: 2-3 months* - This timeframe is far too long for the *start* of immunity following yellow fever vaccination. - By this point, immunity is not only well-established but also **lifelong** (the vaccine provides protection for life after a single dose).

Question 1

What is a key benefit of Randomized Controlled Trials (RCTs) in clinical research?

Accepted Answer

They minimize selection bias.

Answer

They can be conducted more quickly than other study types.

Answer

They are ideal for studying rare diseases.

Answer

They are generally less expensive than other study types.

Question 2

Most commonly used blinding technique in epidemiological studies?

Accepted Answer

Double blinding

Answer

None of the options

Answer

Single blinding

Answer

Triple blinding

Question 3

Which one of the following is NOT a utilization rate?

Accepted Answer

Population bed ratio

Answer

Bed occupancy rate

Answer

Bed turnover ratio

Answer

Average length of stay

Question 4

Which of the following statements is true regarding a combined prospective-retrospective study?

Accepted Answer

Retrospective identification of cohort followed by prospective follow-up

Answer

Only prospective follow-up from current time point

Answer

Cross-sectional assessment at a single time point

Answer

Only retrospective data collection from past records

Question 5

What is the definition of Population Attributable Risk?

Accepted Answer

The difference between incidence in population and incidence in non-exposed.

Answer

The difference between incidence in population and incidence in exposed.

Answer

The difference between incidence in population and incidence in non-exposed compared with incidence in exposed.

Answer

The difference between incidence in exposed and incidence in non-exposed.

Question 6

Which study design is most effective for investigating rare adverse effects of a drug?

Accepted Answer

Case-control study

Answer

Cohort study

Answer

Cross-sectional study

Answer

Clinical trial/experimental study

Question 7

Bladder cancer can occur in those who are working in dye industry for 25 years. Which study design is most appropriate for establishing a causal relationship between dye industry work and bladder cancer?

Accepted Answer

Cohort study

Answer

Cross-sectional study

Answer

Case-control study

Answer

Randomized control trial

Question 8

Which of the following is an example of a case-control study?

Accepted Answer

PVC exposure and angiosarcoma of the liver

Answer

Framingham heart study

Answer

Doll & Hill Study

Answer

Thalidomide exposure and its association with teratogenicity

Question 9

Immunity starts after how many days of yellow fever vaccination ?

Accepted Answer

7-10 days

Answer

2-3 weeks

Answer

4-5 weeks

Answer

2-3 months

Question 10

Which Diphtheria vaccine is recommended for a 14-year-old girl?

Accepted Answer

Tdap vaccine (Tetanus, Diphtheria, Pertussis)

Answer

DT vaccine (Diphtheria, Tetanus)

Answer

No suitable vaccine

Answer

DPT vaccine (Diphtheria, Pertussis, Tetanus)

NEET-PG 2015 — Community Medicine